Acid-sensing ion channel 3 is a new potential therapeutic target for the control of glioblastoma cancer stem cells growth.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
03 09 2024
03 09 2024
Historique:
received:
02
02
2024
accepted:
29
08
2024
medline:
4
9
2024
pubmed:
4
9
2024
entrez:
3
9
2024
Statut:
epublish
Résumé
Glioblastoma (GBM) is the most common malignant primary brain cancer that, despite recent advances in the understanding of its pathogenesis, remains incurable. GBM contains a subpopulation of cells with stem cell-like properties called cancer stem cells (CSCs). Several studies have demonstrated that CSCs are resistant to conventional chemotherapy and radiation thus representing important targets for novel anti-cancer therapies. Proton sensing receptors expressed by CSCs could represent important factors involved in the adaptation of tumours to the extracellular environment. Accordingly, the expression of acid-sensing ion channels (ASICs), proton-gated sodium channels mainly expressed in the neurons of peripheral (PNS) and central nervous system (CNS), has been demonstrated in several tumours and linked to an increase in cell migration and proliferation. In this paper we report that the ASIC3 isoform, usually absent in the CNS and present in the PNS, is enriched in human GBM CSCs while poorly expressed in the healthy human brain. We propose here a novel therapeutic strategy based on the pharmacological activation of ASIC3, which induces a significant GBM CSCs damage while being non-toxic for neurons. This approach might offer a promising and appealing new translational pathway for the treatment of glioblastoma.
Identifiants
pubmed: 39227705
doi: 10.1038/s41598-024-71623-9
pii: 10.1038/s41598-024-71623-9
doi:
Substances chimiques
Acid Sensing Ion Channels
0
ASIC3 protein, human
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
20421Informations de copyright
© 2024. The Author(s).
Références
Sung, H. et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209–249 (2021).
pubmed: 33538338
doi: 10.3322/caac.21660
Reifenberger, G., Wirsching, H.-G., Knobbe-Thomsen, C. B. & Weller, M. Advances in the molecular genetics of gliomas—Implications for classification and therapy. Nat. Rev. Clin. Oncol. 14, 434–452 (2017).
pubmed: 28031556
doi: 10.1038/nrclinonc.2016.204
Stupp, R. et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N. Engl. J. Med. 352, 987–996 (2005).
pubmed: 15758009
doi: 10.1056/NEJMoa043330
Hu, Y. et al. Neural network learning defines glioblastoma features to be of neural crest perivascular or radial glia lineages. Sci. Adv. 8, 6340 (2022).
doi: 10.1126/sciadv.abm6340
Rodríguez-Camacho, A. et al. Glioblastoma treatment: State-of-the-art and future perspectives. Int. J. Mol. Sci. 23(13), 7207 (2022).
pubmed: 35806212
pmcid: 9267036
doi: 10.3390/ijms23137207
Corbet, C. & Feron, O. Tumour acidosis: From the passenger to the driver’s seat. Nat. Rev. Cancer 17(10), 577–593 (2017).
pubmed: 28912578
doi: 10.1038/nrc.2017.77
Ibrahim-Hashim, A. & Estrella, V. Acidosis and cancer: From mechanism to neutralization. Cancer Metastasis Rev. 38, 149–155 (2019).
pubmed: 30806853
pmcid: 6625834
doi: 10.1007/s10555-019-09787-4
Estrella, V. et al. Acidity generated by the tumor microenvironment drives local invasion. Cancer Res. 73, 1524–1535 (2013).
pubmed: 23288510
pmcid: 3594450
doi: 10.1158/0008-5472.CAN-12-2796
Damaghi, M., Wojtkowiak, J. W. & Gillies, R. J. pH sensing and regulation in cancer. Front. Physiol. 4, 370 (2013).
pubmed: 24381558
pmcid: 3865727
doi: 10.3389/fphys.2013.00370
Hjelmeland, A. B. et al. Acidic stress promotes a glioma stem cell phenotype. Cell Death Differ. 18(5), 829–840 (2011).
pubmed: 21127501
doi: 10.1038/cdd.2010.150
Lathia, J. D., Mack, S. C., Mulkearns-Hubert, E. E., Valentim, C. L. L. & Rich, J. N. Cancer stem cells in glioblastoma. Genes Dev. 29, 1203–1217 (2015).
pubmed: 26109046
pmcid: 4495393
doi: 10.1101/gad.261982.115
Lytle, N. K., Barber, A. G. & Reya, T. Stem cell fate in cancer growth, progression and therapy resistance. Nat. Rev. Cancer 18(11), 669–680 (2018).
pubmed: 30228301
pmcid: 8388042
doi: 10.1038/s41568-018-0056-x
Galli, R. et al. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res. 64, 7011–7021 (2004).
pubmed: 15466194
doi: 10.1158/0008-5472.CAN-04-1364
Reya, T., Morrison, S. J., Clarke, M. F. & Weissman, I. L. Stem cells, cancer, and cancer stem cells. Nature 414(6859), 105–111 (2001).
pubmed: 11689955
doi: 10.1038/35102167
Piccirillo, S. G. M. et al. Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells. Nature 444(7120), 761–765 (2006).
pubmed: 17151667
doi: 10.1038/nature05349
Prevarskaya, N., Skryma, R. & Shuba, Y. Ion channels and the hallmarks of cancer. Trends Mol. Med. 16, 107–121 (2010).
pubmed: 20167536
doi: 10.1016/j.molmed.2010.01.005
Liu, C., Zhu, L. L., Xu, S. G., Ji, H. L. & Li, X. M. ENaC/DEG in tumor development and progression. J. Cancer 7, 1888 (2016).
pubmed: 27698929
pmcid: 5039373
doi: 10.7150/jca.15693
Gründer, S., Vanek, J. & Pissas, K. P. Acid-sensing ion channels and downstream signalling in cancer cells: Is there a mechanistic link?. Pflügers Arch.-Eur. J. Physiol. 4, 1–14 (2024).
Chen, B., Liu, J., Ho, T. T., Ding, X. & Mo, Y. Y. ERK-mediated NF-κB activation through ASIC1 in response to acidosis. Oncogene 512(5), e279–e279 (2016).
doi: 10.1038/oncsis.2016.81
King, P. et al. Regulation of gliomagenesis and stemness through acid sensor ASIC1a. Int. J. Oncol. 59, 1–15 (2021).
doi: 10.3892/ijo.2021.5262
Tian, Y. et al. Glioblastoma cancer stem cell lines express functional acid sensing ion channels ASIC1a and ASIC3. Sci. Rep. 7, 1–14 (2017).
doi: 10.1038/s41598-017-13666-9
Wemmie, J. A. et al. Acid-sensing ion channels in pain and disease. Nat. Rev. Neurosci. 14(7), 461–471 (2013).
pubmed: 23783197
pmcid: 4307015
doi: 10.1038/nrn3529
Boscardin, E., Alijevic, O., Hummler, E., Frateschi, S. & Kellenberger, S. The function and regulation of acid-sensing ion channels (ASICs) and the epithelial Na+ channel (ENaC): IUPHAR review 19. Br. J. Pharmacol. 173, 2671–2701 (2016).
pubmed: 27278329
pmcid: 4995293
doi: 10.1111/bph.13533
Wemmie, J. A. et al. Acid-sensing ion channel 1 is localized in brain regions with high synaptic density and contributes to fear conditioning. J. Neurosci. 23, 5496–5502 (2003).
pubmed: 12843249
pmcid: 6741257
doi: 10.1523/JNEUROSCI.23-13-05496.2003
Baron, A., Voilley, N., Lazdunski, M. & Lingueglia, E. Acid sensing ion channels in dorsal spinal cord neurons. J. Neurosci. 28, 1498–1508 (2008).
pubmed: 18256271
pmcid: 6671562
doi: 10.1523/JNEUROSCI.4975-07.2008
Deval, E. et al. ASIC3, a sensor of acidic and primary inflammatory pain. EMBO J. 27, 3047–3055 (2008).
pubmed: 18923424
pmcid: 2585165
doi: 10.1038/emboj.2008.213
Lin, Y. W. et al. Identification and characterization of a subset of mouse sensory neurons that express acid-sensing ion channel 3. Neuroscience 151, 544–557 (2008).
pubmed: 18082972
doi: 10.1016/j.neuroscience.2007.10.020
Zhang, Z. et al. Acid-sensing ion channel 1a modulation of apoptosis in acidosis-related diseases: Implications for therapeutic intervention. Cell Death Discov. 9(1), 330 (2023).
pubmed: 37666823
pmcid: 10477349
doi: 10.1038/s41420-023-01624-6
Wang, Y., Zhou, H., Sun, Y. & Huang, Y. Acid-sensing ion channel 1: Potential therapeutic target for tumor. Biomed. Pharmacother. 155, 113835 (2022).
pubmed: 36271585
doi: 10.1016/j.biopha.2022.113835
Gupta, S. C. et al. Regulation of breast tumorigenesis through acid sensors. Oncogene 35(31), 4102–4111 (2016).
pubmed: 26686084
doi: 10.1038/onc.2015.477
Zhu, S. et al. ASIC1 and ASIC3 contribute to acidity-induced EMT of pancreatic cancer through activating Ca2+/RhoA pathway. Cell Death Dis. 8(5), e2806–e2806 (2017).
pubmed: 28518134
pmcid: 5520710
doi: 10.1038/cddis.2017.189
Berdiev, B. K. et al. Acid-sensing ion channels in malignant gliomas. J. Biol. Chem. 278, 15023–15034 (2003).
pubmed: 12584187
doi: 10.1074/jbc.M300991200
Litan, A. & Langhans, S. A. Cancer as a channelopathy: Ion channels and pumps in tumor development and progression. Front. Cell. Neurosci. 9, 132394 (2015).
doi: 10.3389/fncel.2015.00086
Yang, M. & Brackenbury, W. J. Membrane potential and cancer progression. Front. Physiol. 4, 185 (2013).
pubmed: 23882223
pmcid: 3713347
doi: 10.3389/fphys.2013.00185
Niklasson, M. et al. Membrane-depolarizing channel blockers induce selective glioma cell death by impairing nutrient transport and unfolded protein/amino acid responses. Cancer Res. 77, 1741–1752 (2017).
pubmed: 28087597
doi: 10.1158/0008-5472.CAN-16-2274
Li, W. G., Yu, Y., Zhang, Z. D., Cao, H. & Xu, T. L. ASIC3 channels integrate agmatine and multiple inflammatory signals through the nonproton ligand sensing domain. Mol. Pain 6, 1744–8069 (2010).
doi: 10.1186/1744-8069-6-88
Agharkar, A. S. & Gonzales, E. B. 4-Chlorophenylguanidine is an ASIC3 agonist and positive allosteric modulator. J. Pharmacol. Sci. 133, 184–186 (2017).
pubmed: 28259560
doi: 10.1016/j.jphs.2017.02.007
Callejo, G. et al. In silico screening of GMQ-like compounds reveals guanabenz and sephin1 as new allosteric modulators of acid-sensing ion channel 3. Biochem. Pharmacol. 174, 113834 (2020).
pubmed: 32027884
pmcid: 7068650
doi: 10.1016/j.bcp.2020.113834
Yu, Y. et al. A nonproton ligand sensor in the acid-sensing ion channel. Neuron 68, 61–72 (2010).
pubmed: 20920791
doi: 10.1016/j.neuron.2010.09.001
Besson, T., Lingueglia, E. & Salinas, M. Pharmacological modulation of acid-sensing ion channels 1a and 3 by amiloride and 2-guanidine-4-methylquinazoline (GMQ). Neuropharmacology 125, 429–440 (2017).
pubmed: 28802647
doi: 10.1016/j.neuropharm.2017.08.004
Delaunay, A. et al. Human ASIC3 channel dynamically adapts its activity to sense the extracellular pH in both acidic and alkaline directions. Proc. Natl. Acad. Sci. USA 109, 13124–13129 (2012).
pubmed: 22829666
pmcid: 3420194
doi: 10.1073/pnas.1120350109
Foster, V. S. et al. Acid-sensing ion channels: Expression and function in resident and infiltrating immune cells in the central nervous system. Front. Cell. Neurosci. 15, 738043 (2021).
pubmed: 34602982
pmcid: 8484650
doi: 10.3389/fncel.2021.738043
Minghua, L. et al. Acid-sensing ion channels in acidosis-induced injury of human brain neurons. J. Cereb. Blood Flow Metab. 30, 1247–1260 (2010).
doi: 10.1038/jcbfm.2010.30
Bortner, C. D., Gómez-Angelats, M. & Cidlowski, J. A. Plasma membrane depolarization without repolarization is an early molecular event in anti-Fas-induced apoptosis. J. Biol. Chem. 276, 4304–4314 (2001).
pubmed: 11050080
doi: 10.1074/jbc.M005171200
Narayanan, A. et al. The proneural gene ASCL1 governs the transcriptional subgroup affiliation in glioblastoma stem cells by directly repressing the mesenchymal gene NDRG1. Cell Death Differ. 26(9), 1813–1831 (2019).
pubmed: 30538287
doi: 10.1038/s41418-018-0248-7
Di Tomaso, T. et al. Immunobiological characterization of cancer stem cells isolated from glioblastoma patients. Clin. Cancer Res. 16, 800–813 (2010).
pubmed: 20103663
pmcid: 2842003
doi: 10.1158/1078-0432.CCR-09-2730
De Ceglia, R. et al. Down-sizing of neuronal network activity and density of presynaptic terminals by pathological acidosis are efficiently prevented by diminazene aceturate. Brain Behav. Immun. 45, 263–276 (2015).
pubmed: 25499583
doi: 10.1016/j.bbi.2014.12.003
Pahari S., Sun L., & Alexov E. PKAD: A database of experimentally measured pKa values of ionizable groups in proteins. Database baz024 (2019)
Yoder, N. & Gouaux, E. The his-gly motif of acid-sensing ion channels resides in a reentrant ‘loop’ implicated in gating and ion selectivity. Elife 9, 1–18 (2020).
doi: 10.7554/eLife.56527
Abraham, M. J. et al. GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX 1–2, 19–25 (2015).
doi: 10.1016/j.softx.2015.06.001
Schmid, N. et al. Definition and testing of the GROMOS force-field versions 54A7 and 54B7. Eur. Biophys. J. 40, 843–856 (2011).
pubmed: 21533652
doi: 10.1007/s00249-011-0700-9
Sanner, M. F. Python: A programming language for software integration and development. J. Mol. Graph Model. 17, 57–61 (1999).
pubmed: 10660911
Trott, O. & Olson, A. J. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem. 31(2), 455–461 (2010).
pubmed: 19499576
pmcid: 3041641
doi: 10.1002/jcc.21334
Morris, G. M. et al. AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J. Comput. Chem. 30, 2785–2791 (2009).
pubmed: 19399780
pmcid: 2760638
doi: 10.1002/jcc.21256
Casella, G. et al. IL4 induces IL6-producing M2 macrophages associated to inhibition of neuroinflammation in vitro and in vivo. J. Neuroinflamm. 13, 1–10 (2016).
doi: 10.1186/s12974-016-0596-5
Rahman, M. et al. Neurosphere and adherent culture conditions are equivalent for malignant glioma stem cell lines. Anat. Cell Biol. 48, 25–35 (2015).
pubmed: 25806119
pmcid: 4371178
doi: 10.5115/acb.2015.48.1.25
Cortés Franco K.D. et al. Aggressive migration in acidic pH of a glioblastoma cancer stem cell line in vitro is independent of ASIC and KCa3.1 ion channels, but involves phosphoinositide 3-kinase. Pflugers Arch. Eur. J. Physiol. 475, 405–416 (2023)
Zhou, Z. H. et al. The acid-sensing ion channel, ASIC2, promotes invasion and metastasis of colorectal cancer under acidosis by activating the calcineurin/NFAT1 axis. J. Exp. Clin. Cancer Res. 36, 1–12 (2017).
doi: 10.1186/s13046-017-0599-9
Qian, H. Y. et al. Metformin attenuates bone cancer pain by reducing TRPV1 and ASIC3 expression. Front. Pharmacol. 12, 713944 (2021).
pubmed: 34421611
pmcid: 8371459
doi: 10.3389/fphar.2021.713944
Poon, M. T. C., Bruce, M., Simpson, J. E., Hannan, C. J. & Brennan, P. M. Temozolomide sensitivity of malignant glioma cell lines—A systematic review assessing consistencies between in vitro studies. BMC Cancer 21, 1–9 (2021).
doi: 10.1186/s12885-021-08972-5
Cidado, J. et al. Ki-67 is required for maintenance of cancer stem cells but not cell proliferation. Oncotarget 7, 6281 (2016).
pubmed: 26823390
pmcid: 4868756
doi: 10.18632/oncotarget.7057
Wu, Y. et al. Acid-sensing ion channels contribute to the effect of extracellular acidosis on proliferation and migration of A549 cells. Tumor Biol. 39, 12 (2017).
doi: 10.1177/1010428317705750
Alijevic, O. & Kellenberger, S. Subtype-specific modulation of acid-sensing ion channel (ASIC) function by 2-guanidine-4-methylquinazoline. J. Biol. Chem. 287, 36059–36070 (2012).
pubmed: 22948146
pmcid: 3476274
doi: 10.1074/jbc.M112.360487
Diochot, S. et al. A new sea anemone peptide, APETx2, inhibits ASIC3, a major acid-sensitive channel in sensory neurons. EMBO J. 23, 1516–1525 (2004).
pubmed: 15044953
pmcid: 391081
doi: 10.1038/sj.emboj.7600177
Beier, D. et al. Temozolomide preferentially depletes cancer stem cells in glioblastoma. Cancer Res. 68, 5706–5715 (2008).
pubmed: 18632623
doi: 10.1158/0008-5472.CAN-07-6878
Wu, Y., Franzmeier, S., Liesche-Starnecker, F. & Schlegel, J. Enhanced sensitivity to ALDH1A3-dependent ferroptosis in TMZ-resistant glioblastoma cells. Cells 12(21), 2522 (2023).
pubmed: 37947601
pmcid: 10649134
doi: 10.3390/cells12212522
Yuan, X. et al. Isolation of cancer stem cells from adult glioblastoma multiforme. Oncogene 23, 9392–9400 (2004).
pubmed: 15558011
doi: 10.1038/sj.onc.1208311
Laks, D. R. et al. Neurosphere formation is an independent predictor of clinical outcome in malignant glioma. Stem cells 27, 980–987 (2009).
pubmed: 19353526
doi: 10.1002/stem.15
Hu, Y. & Gordon, K. S. ELDA: Extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays. J. Immunol. Methods 347, 70–78 (2009).
pubmed: 19567251
doi: 10.1016/j.jim.2009.06.008
Deval, E. et al. Acid-sensing ion channels in postoperative pain. J. Neurosci. 31, 6059–6066 (2011).
pubmed: 21508231
pmcid: 6632959
doi: 10.1523/JNEUROSCI.5266-10.2011
Wang, D. et al. Effects of hypoxia and ASIC3 on nucleus pulposus cells: From cell behavior to molecular mechanism. Biomed. Pharmacother. 117, 109061 (2019).
pubmed: 31202172
doi: 10.1016/j.biopha.2019.109061
Walker, K. & Hjelmeland, A. Method for efficient transduction of cancer stem cells. J. Cancer Stem Cell Res. 2, 1 (2014).
doi: 10.14343/JCSCR.2014.2e1008
Rooj, A. K. et al. Glioma-specific cation conductance regulates migration and cell cycle progression. J. Biol. Chem. 287, 4053–4065 (2012).
pubmed: 22130665
doi: 10.1074/jbc.M111.311688
Kapoor, N. et al. Knockdown of ASIC1 and epithelial sodium channel subunits inhibits glioblastoma whole cell current and cell migration. J. Biol. Chem. 284, 24526–24541 (2009).
pubmed: 19561078
pmcid: 2782044
doi: 10.1074/jbc.M109.037390
Kellenberger, S. & Schild, L. International Union of Basic and Clinical Pharmacology. XCI. Structure, function, and pharmacology of acid-sensing ion channels and the epithelial Na+ channel. Pharmacol. Rev. 67, 1–35 (2015).
pubmed: 25287517
doi: 10.1124/pr.114.009225
Cheng, Q. et al. Novel insights into ion channels in cancer stem cells (review). Int. J. Oncol. 53, 1435–1441 (2018).
pubmed: 30066845
Takayasu, T., Kurisu, K., Esquenazi, Y. & Ballester, L. Y. Ion channels and their role in the pathophysiology of gliomas. Mol. Cancer Ther. 19, 1959–1969 (2020).
pubmed: 33008831
pmcid: 7577395
doi: 10.1158/1535-7163.MCT-19-0929
Pollak, J. et al. Ion channel expression patterns in glioblastoma stem cells with functional and therapeutic implications for malignancy. PLoS One 12, e0172884 (2017).
pubmed: 28264064
pmcid: 5338779
doi: 10.1371/journal.pone.0172884
Pöhlmann, J. et al. High costs, low quality of life, reduced survival, and room for improving treatment: An analysis of burden and unmet needs in glioma. Front. Oncol. 14, 1368606 (2024).
pubmed: 38571509
pmcid: 10987841
doi: 10.3389/fonc.2024.1368606
Li, W. G. & Xu, T. L. ASIC3 channels in multimodal sensory perception. ACS Chem. Neurosci. 2, 26–37 (2011).
pubmed: 22778854
doi: 10.1021/cn100094b
Dulai, J. S., Smith, E. S. J. & Rahman, T. Acid-sensing ion channel 3: An analgesic target. Channels 15, 94–127 (2021).
pubmed: 33258401
pmcid: 7801124
doi: 10.1080/19336950.2020.1852831